… This trapping mechanism provides an excellent means for development and application of
analytical models for the measurement of CMRGlc with PCT. Like DG, FDG has been shown …

This study investigated cerebral glucose metabolism in very early Alzheimer's disease,
before a clinical diagnosis of probable Alzheimer's disease is possible, using [ 18 F]…

… phosphorylated DG is not a substrate for further metabolic reactions (3, 11, 34): the permeability
of cell membranes to the phosphorylated DG’ is low (36), and the reverse reaction of de…

… Z-score for normalcontrols, a jackknife-typeprocedurewas used as de scribed in the next …
AlthOUghasymmetty in the de gree ofmetabolic reduction can exist (4,9,10,15,18—20),both …

… is the failure of the detector system to resolve … de scrutinage currentemente in uso, le
imagines de omne nivellos del corpore se superimpone in le complete registration. Le imagine de …

A convenient method for the synthesis of 18 F‐2‐deoxy‐2‐fluoro‐D‐glucose (4) and 18 F‐2‐deoxy‐2‐fluoro‐D‐mannose
(8) by the direct fluorination of 3,4,6‐tri‐0‐acetyl‐D‐glucal with …

… , represents the combined processes of ry of the ~dion~cl~de to the tissue by bl at-action of
the tracer across the capiil ce ma single capillary transit and must have units of tissue per min…

Seeking antemortem markers to distinguish Dementia with Lewy bodies (DLB) and Alzheimer's
disease (AD), we examined brain glucose metabolism of DLB and AD. Eleven DLB …

We have characterized N-13 ammonia as a myocardial blood flow imaging agent suitable
for positron-emission computed tomography. However, themechanisms of uptake and …

… Instead, our data are more likely consistent with a cholinergic degenerative process in
which enzymatic activity fails prior to actual loss of terminals. Our scan measures of cholinergic …